Cencora (COR) Revenue (2009 - 2026)

Cencora (COR) reported Revenue of $78.4 billion for Q1 2026, up 3.85% on a YoY basis from $75.5 billion in Q1 2025, and down 8.82% quarter-over-quarter from $85.9 billion in Q4 2025.

Cencora (COR) Revenue (2009 - 2026) Analysis & Trends

Cencora has reported Revenue for 18 years, with the latest figure at $78.4 billion in Q1 2026.

  • For the quarter ending Q1 2026, Revenue rose 3.85% year-over-year to $78.4 billion; the trailing twelve-month figure through Mar 2026 stood at $328.7 billion (up 5.95% YoY), and the FY2025 full-year result was $321.3 billion, up 9.31% from the prior year.
  • Revenue for Q1 2026 stood at $78.4 billion, down from $85.9 billion in the prior quarter.
  • The five-year high for Revenue was $207.3 billion in Q3 2022, with the low at $57.7 billion in Q1 2022.
  • Historically, Revenue has averaged $80.4 billion across 5 years, with a median of $74.2 billion in 2024.
  • Annual changes were most pronounced in 2022 — Revenue surged 4324.98% — and 2023, when it plunged 66.75%.
  • Cencora's Revenue stood at $62.8 billion in 2022, then grew by 14.97% to $72.3 billion in 2023, then increased by 12.78% to $81.5 billion in 2024, then rose by 5.45% to $85.9 billion in 2025, then declined by 8.82% to $78.4 billion in 2026.
  • The last three Revenue figures came in at $78.4 billion (Q1 2026), $85.9 billion (Q4 2025), and $83.7 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Akso Health 2,315,158.81 Bn 2,315,158.63 Bn - -
2 Mckesson 92.76 Bn 89.18 Bn 4.04 Bn 96.30 Bn
3 Cencora 52.82 Bn 50.83 Bn 3.59 Bn 78.36 Bn
4 Cardinal Health 52.17 Bn 48.39 Bn 2.50 Bn 60.94 Bn
5 Henry Schein 9.19 Bn 9.71 Bn 1.07 Bn 3.37 Bn
6 Accendra Health 246.88 Mn -90.00 Mn 312.39 Mn 627.78 Mn
7 Edap Tms 161.92 Mn 146.92 Mn 8.15 Mn 17.81 Mn
8 111 107.47 Mn 25.61 Mn 23.58 Mn 403.28 Mn
9 Cosmos Health 9.42 Mn 7.26 Mn 1.38 Mn 17.93 Mn
10 Cellyan Biotechnology 5.69 -2.48 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 78.36 Bn
Dec 31, 2025 85.93 Bn
Sep 30, 2025 83.73 Bn
Jun 30, 2025 80.66 Bn
Mar 31, 2025 75.45 Bn
Dec 31, 2024 81.49 Bn
Sep 30, 2024 79.05 Bn
Jun 30, 2024 74.24 Bn
Mar 31, 2024 68.41 Bn
Dec 31, 2023 72.25 Bn
Sep 30, 2023 68.92 Bn
Jun 30, 2023 66.95 Bn
Mar 31, 2023 63.46 Bn
Dec 31, 2022 62.85 Bn
Sep 30, 2022 207.28 Bn
Jun 30, 2022 60.06 Bn
Mar 31, 2022 57.72 Bn
Dec 31, 2021 59.63 Bn
Sep 30, 2021 4.68 Bn
Jun 30, 2021 53.41 Bn